Ascorbic Acid Found to Reduce Darbepoetin Requirement
It also was associated with high hemoglobin levels and reduced levels of C-reactive protein.
NKF 2014 Anemia
Value of ESAs in Avoiding Transfusion Questionable
In 3 trials, the annual cost for preventing 1 patient from being transfused varied from $61,188 to $317,988.
Anemia Management Changing in Peritoneal Dialysis Patients
Study reveals a decline in the use of erythropoiesis-stimulating agents and an increase in the use of iron.
Inappropriate ESA Use Reduced by Pharmacy Protocol
Ordering process cut the number of epoetin alfa doses by 71% and medication costs by 69%.
Safety Profiles of IV Iron Products Compared
In a head-to-head comparison, researchers observed a higher rate of adverse events with iron dextran than iron sucrose or ferric gluconate.
Phosphate Binder May Eliminate Need for IV Iron
Iron absorbed from oral ferric citrate boosted iron stores and sustained hemoglobin levels.
Want to read more?
Please login or register first to view this content.